End-of-day quote
Johannesburg S.E.
06:00:00 2024-05-30 pm EDT
|
5-day change
|
1st Jan Change
|
31.28
ZAR
|
-4.63%
|
|
-8.22%
|
+1.92%
|
Fiscal Period: February |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
22,190
|
18,595
|
19,254
|
29,767
|
23,265
|
26,878
|
-
|
-
|
Enterprise Value (EV)
1 |
23,832
|
21,842
|
23,190
|
33,569
|
27,952
|
26,242
|
29,255
|
28,315
|
P/E ratio
|
30.2
x
|
31.1
x
|
28.8
x
|
34.9
x
|
23.3
x
|
26.6
x
|
21.3
x
|
18.3
x
|
Yield
|
1.33%
|
0.59%
|
1.39%
|
1.15%
|
1.72%
|
1.49%
|
1.91%
|
2.27%
|
Capitalization / Revenue
|
1.04
x
|
0.78
x
|
0.73
x
|
0.98
x
|
0.71
x
|
0.72
x
|
0.67
x
|
0.6
x
|
EV / Revenue
|
1.11
x
|
0.91
x
|
0.88
x
|
1.1
x
|
0.86
x
|
0.72
x
|
0.73
x
|
0.64
x
|
EV / EBITDA
|
17
x
|
12
x
|
11.8
x
|
14
x
|
10.2
x
|
9.09
x
|
8.68
x
|
7.44
x
|
EV / FCF
|
-
|
24.4
x
|
32.1
x
|
-
|
-118
x
|
16.4
x
|
16.4
x
|
14.5
x
|
FCF Yield
|
-
|
4.09%
|
3.12%
|
-
|
-0.84%
|
6.11%
|
6.1%
|
6.88%
|
Price to Book
|
10.5
x
|
8.04
x
|
6.53
x
|
8.8
x
|
5.92
x
|
5.93
x
|
5.09
x
|
4.38
x
|
Nbr of stocks (in thousands)
|
860,084
|
860,084
|
859,553
|
859,829
|
860,084
|
859,269
|
-
|
-
|
Reference price
2 |
25.80
|
21.62
|
22.40
|
34.62
|
27.05
|
31.28
|
31.28
|
31.28
|
Announcement Date
|
5/16/19
|
5/20/20
|
5/21/21
|
5/23/22
|
5/18/23
|
5/31/24
|
-
|
-
|
Fiscal Period: February |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
21,420
|
23,984
|
26,278
|
30,407
|
32,664
|
36,283
|
40,149
|
44,474
|
EBITDA
1 |
1,404
|
1,824
|
1,971
|
2,394
|
2,746
|
2,886
|
3,370
|
3,807
|
EBIT
1 |
1,218
|
1,248
|
1,266
|
1,539
|
1,744
|
1,779
|
2,149
|
2,441
|
Operating Margin
|
5.69%
|
5.21%
|
4.82%
|
5.06%
|
5.34%
|
4.9%
|
5.35%
|
5.49%
|
Earnings before Tax (EBT)
1 |
1,056
|
868.8
|
940.9
|
1,227
|
1,417
|
1,385
|
1,764
|
2,040
|
Net income
1 |
734.7
|
598.2
|
668.7
|
853.4
|
1,000
|
984.5
|
1,259
|
1,447
|
Net margin
|
3.43%
|
2.49%
|
2.54%
|
2.81%
|
3.06%
|
2.71%
|
3.14%
|
3.25%
|
EPS
2 |
0.8540
|
0.6960
|
0.7780
|
0.9920
|
1.163
|
1.147
|
1.466
|
1.706
|
Free Cash Flow
1 |
-
|
893.6
|
722.9
|
-
|
-236
|
1,834
|
1,784
|
1,949
|
FCF margin
|
-
|
3.73%
|
2.75%
|
-
|
-0.72%
|
5.06%
|
4.44%
|
4.38%
|
FCF Conversion (EBITDA)
|
-
|
48.99%
|
36.68%
|
-
|
-
|
63.42%
|
52.92%
|
51.19%
|
FCF Conversion (Net income)
|
-
|
149.38%
|
108.1%
|
-
|
-
|
180.86%
|
141.68%
|
134.67%
|
Dividend per Share
2 |
0.3420
|
0.1280
|
0.3110
|
0.3970
|
0.4660
|
0.4650
|
0.5983
|
0.7099
|
Announcement Date
|
5/16/19
|
5/20/20
|
5/21/21
|
5/23/22
|
5/18/23
|
5/31/24
|
-
|
-
|
Fiscal Period: February |
2020 S1
|
2020 S2
|
2021 S1
|
2021 S2
|
2022 S1
|
2023 S1
|
---|
Net sales
|
11,848
|
12,137
|
12,807
|
13,471
|
14,936
|
-
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
|
-
|
-
|
-
|
-
|
-
|
-
|
Operating Margin
|
-
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
|
388.1
|
-
|
-
|
-
|
-
|
-
|
Net income
1 |
-
|
-
|
-
|
-
|
-
|
602.5
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
2 |
0.3100
|
0.3860
|
0.3600
|
0.4180
|
0.4840
|
0.7000
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
11/7/19
|
5/20/20
|
11/5/20
|
5/21/21
|
11/3/21
|
9/30/22
|
Fiscal Period: February |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
1,641
|
3,247
|
3,936
|
3,802
|
4,687
|
3,124
|
2,377
|
1,437
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
1.169
x
|
1.78
x
|
1.997
x
|
1.588
x
|
1.707
x
|
1.081
x
|
0.7054
x
|
0.3775
x
|
Free Cash Flow
1 |
-
|
894
|
723
|
-
|
-236
|
1,834
|
1,784
|
1,949
|
ROE (net income / shareholders' equity)
|
40.1%
|
28.9%
|
25.9%
|
27.4%
|
27.7%
|
23.5%
|
25.3%
|
25.3%
|
ROA (Net income/ Total Assets)
|
-
|
5.67%
|
5.63%
|
-
|
6.76%
|
6.43%
|
7.44%
|
8%
|
Assets
1 |
-
|
10,554
|
11,885
|
-
|
14,796
|
15,774
|
16,926
|
18,082
|
Book Value Per Share
2 |
2.450
|
2.690
|
3.430
|
3.940
|
4.570
|
5.270
|
6.150
|
7.150
|
Cash Flow per Share
2 |
1.070
|
-
|
-
|
1.600
|
0.9900
|
1.910
|
2.590
|
3.120
|
Capex
1 |
395
|
363
|
401
|
377
|
1,090
|
971
|
905
|
921
|
Capex / Sales
|
1.84%
|
1.51%
|
1.53%
|
1.24%
|
3.34%
|
2.68%
|
2.25%
|
2.07%
|
Announcement Date
|
5/16/19
|
5/20/20
|
5/21/21
|
5/23/22
|
5/18/23
|
5/31/24
|
-
|
-
|
Last Close Price
31.28
ZAR Average target price
30.6
ZAR Spread / Average Target -2.17% Consensus |
1st Jan change
|
Capi.
|
---|
| +1.92% | 1.43B | | -37.88% | 13.99B | | -33.12% | 10.67B | | +12.54% | 6.29B | | -11.17% | 5.88B | | +75.00% | 4.96B | | -2.92% | 4.54B | | -9.20% | 3.74B | | -19.40% | 3.16B | | -12.15% | 2.85B |
Other Drug Retailers
|